Makary has been a prominent voice on U.S. health care practices whose research focuses on the underlying causes of disease, ...

The public-health establishment and left-wing media are rushing to discredit President-elect Donald Trump’s picks to lead ...

(Goldman, 11/27) Bloomberg: Hims & Hers Shares Rally As FDA Pick Marty Makary Seen As Major Ally Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the ...

Trump’s FDA pick, Marty Makary, appears to be quelling fears about a major disruption to biotech and pharma. Neuralink ...

Marty Makary, a Johns Hopkins surgeon and outspoken critic of parts of the U.S. medical system, is Trump’s pick for FDA ...

Learn about President-elect Trump's pick for FDA head, Dr. Marty Makary, a pancreatic surgeon and professor at Johns Hopkins — and a telehealth executive.

Front-month gold futures fell Monday in the largest one-day decline by dollar amount since November 2020, as news of a ...

Hims & Hers Health (HIMS) has soared after Hunterbrook Media says that the company could benefit from President-elect Donald ...

Traders and investors watched Wall Street's major averages finish Monday on a positive note where the blue-chip Dow outshined ...

After going short the stock in June based on Hunterbrook Media’s reporting, Hunterbrook Capital said today it is long Hims & Hers Health.

Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...

Donald Trump’s picks for healthcare leaders are a mixed bag for vaccine makers, makers of weight-loss drugs, and insurers.